Deep Health AI India Limited Announces Resignation of Independent Director

1 min read     Updated on 03 Apr 2026, 09:32 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Deep Health AI India Limited announced the resignation of Independent Director Mr. Kailash Chandra, effective April 03, 2026. The resignation was communicated to BSE Limited with complete regulatory compliance under SEBI guidelines, including proper documentation and confirmation that no material reasons existed beyond personal circumstances.

powered bylight_fuzz_icon
36777434

*this image is generated using AI for illustrative purposes only.

Deep Health AI India Limited has formally notified BSE Limited about the resignation of Mr. Kailash Chandra from his position as Independent Director, effective from the close of business hours on April 03, 2026. The announcement was made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Director Resignation Details

The resignation was communicated through an official letter dated April 03, 2026, addressed to BSE Limited. The company provided comprehensive details as required under regulatory guidelines, including annexures containing the resignation letter and detailed information about the departing director.

Parameter: Details
Director Name: Mr. Kailash Chandra
DIN: 10985611
Position: Independent Director
Resignation Date: April 03, 2026
Effective From: Close of business hours, April 03, 2026
Reason: Personal reasons
Scrip Code: 539559

Board Committee Memberships

Mr. Kailash Chandra held significant responsibilities within the company's governance structure. His committee memberships included key oversight roles that are essential for corporate governance and regulatory compliance.

Committee: Membership Status
Audit Committee: Member
Nomination & Remuneration Committee: Member
Stakeholder & Relationship Committee: Member

Regulatory Compliance

The company has fulfilled all regulatory requirements associated with the director's resignation. In his resignation letter, Mr. Kailash Chandra confirmed that there were no material reasons for his departure other than personal circumstances. The director was associated solely with Deep Health AI India Limited and did not hold directorship positions in any other listed entities.

The resignation letter was submitted with proper acknowledgment and digital signature verification. The filing was made pursuant to SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated January 30, 2026, ensuring complete regulatory compliance.

Company Background

Deep Health AI India Limited, formerly known as Deep Diamond India Limited, operates from its registered office in Udaipur, Rajasthan. The company's Managing Director, Mr. Narayan Singh Rathore (DIN: 10900646), signed the regulatory filing that was submitted to the stock exchange.

The resignation represents a change in the company's board composition, with the departure of an independent director who served on multiple key committees responsible for audit oversight, executive compensation, and stakeholder relations.

Historical Stock Returns for Deep Health AI

1 Day5 Days1 Month6 Months1 Year5 Years
-4.97%-17.70%-41.30%-62.36%-58.65%+35.43%

How will Deep Health AI India Limited restructure its board committees to fill the governance gap left by Mr. Kailash Chandra's departure from three key committees?

What impact might the loss of an independent director have on Deep Health AI's corporate governance ratings and investor confidence?

Will the company need to expedite the appointment of a new independent director to maintain regulatory compliance and board independence ratios?

Deep Health AI India Limited Board Approves Voluntary Strike-Off of Wholly Owned Subsidiary

1 min read     Updated on 02 Apr 2026, 05:28 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Deep Health AI India Limited's Board of Directors approved the voluntary strike-off of its wholly owned subsidiary Microcure Biotech Private Limited during a meeting on April 01, 2026. The subsidiary, which has no business operations and contributed nil turnover with Rs. 2,00,000 net worth in FY 24-25, will be struck off under Section 248(2) of the Companies Act, 2013. The company has fulfilled regulatory compliance by notifying BSE Limited under Regulation 30 of SEBI Listing Regulations, with Managing Director Narayan Singh Rathore confirming no material impact on operations.

powered bylight_fuzz_icon
36632815

*this image is generated using AI for illustrative purposes only.

Deep Health AI India Limited has announced that its Board of Directors approved the voluntary strike-off of wholly owned subsidiary Microcure Biotech Private Limited during a board meeting held on April 01, 2026. The decision was made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Decision

The board approved filing an application under Section 248(2) of the Companies Act, 2013 for striking off Microcure Biotech Private Limited. The subsidiary is not carrying on any business operations and does not qualify as a material subsidiary of the company.

Meeting Details: Information
Date: April 01, 2026
Start Time: 03:30 P.M.
End Time: 06:05 P.M.
Approval: Voluntary strike-off application

Subsidiary Financial Contribution

The wholly owned subsidiary's contribution to Deep Health AI India Limited during the last financial year was minimal, reflecting its inactive status.

Financial Parameter: FY 24-25 Performance
Turnover: NIL
Net Worth: Rs. 2,00,000
Business Operations: None
Material Subsidiary Status: Does not qualify

Regulatory Compliance and Documentation

The company has submitted the board meeting outcome to BSE Limited, fulfilling its disclosure obligations under Regulation 30 of the Listing Regulations. Managing Director Narayan Singh Rathore signed the official communication, which was digitally authenticated on April 01, 2026.

Regulatory Details: Information
Communication Date: April 01, 2026
Recipient: BSE Limited
Digital Signature Time: 18:45:11 +05'30'
Annexure: Detailed subsidiary disclosures

Impact Assessment

Deep Health AI India Limited has clarified that the voluntary strike-off of Microcure Biotech Private Limited will have no material impact on the company's operations or financial position. The decision appears to be part of corporate housekeeping to streamline the company's subsidiary structure.

Company Background

Deep Health AI India Limited, formerly known as Deep Diamond India Limited, is registered in Udaipur, Rajasthan. The company operates from its registered office at 506-509 Fifth floor, Apeksha, plot no. 256, Main Road, Hiran Magri, Sector 11, Udaipur, Rajasthan. The company's CIN is L24100MH1994PLC082609.

Historical Stock Returns for Deep Health AI

1 Day5 Days1 Month6 Months1 Year5 Years
-4.97%-17.70%-41.30%-62.36%-58.65%+35.43%

Will Deep Health AI India Limited acquire or establish new subsidiaries to strengthen its AI healthcare portfolio following this corporate restructuring?

How might this subsidiary consolidation strategy affect Deep Health AI's operational efficiency and cost structure in the upcoming quarters?

Could this streamlining move signal preparation for potential fundraising, IPO plans, or strategic partnerships in the AI healthcare sector?

More News on Deep Diamond

1 Year Returns:-58.65%